The total number of scientific publications in pharmaceutical science in South Korea has shown a robust upward trend. As of 2023, there were 591.12 publications, marking a substantial increase from 244.64 in 2013. Reviewing the historical data, noticeable increases include an 11.84% year-on-year boost in 2014 and an expansive 15.92% rise in 2021. The latest recorded data shows an 11.96% year-on-year surge by 2023. Over the past five years, the average annual growth rate (CAGR) was 14.35%, reflecting a dynamic and accelerating research climate.
Looking ahead, forecasts indicate a continuance of this robust growth, with the total number of publications anticipated to reach 902.24 by 2028, guided by an average CAGR of 6.65% over the next five years. This suggests a sustained, albeit slightly moderated, growth trajectory.
Future trends to watch:
- Increased collaboration between academia and industry, fostering higher publication rates.
- Expanding government funding for pharmaceutical research, driving innovation and publication output.
- Advancements in biotechnology and genomics, potentially leading to new research avenues and publications.
- Global health challenges and pandemics, influencing research priorities and publication volume.
